There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apyx Medical (APYX – Research Report) and Simulations Plus (SLP – Research Report) with bullish sentiments.
Apyx Medical (APYX)
Craig-Hallum analyst Greg Palm maintained a Buy rating on Apyx Medical today and set a price target of $10.00. The company’s shares closed last Monday at $5.29.
According to TipRanks.com, Palm is a 4-star analyst with an average return of
Apyx Medical has an analyst consensus of Strong Buy, with a price target consensus of $7.67.
See the top stocks recommended by analysts >>
Simulations Plus (SLP)
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Simulations Plus today. The company’s shares closed last Monday at $44.16.
According to TipRanks.com, Hewitt is a 4-star analyst with an average return of
Simulations Plus has an analyst consensus of Strong Buy, with a price target consensus of $61.00, implying a 41.0% upside from current levels. In a report issued on June 21, Oppenheimer also reiterated a Buy rating on the stock with a $67.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on APYX:
